Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival

Table 3 Relationship Between Expression of E-cadherin or β-catenin and Histopathological Features in Gastric Carcinoma

	No	E-cadherin expression (%)		β-catenin expression (%)
		Abnormal	P value	Abnormal	P value
pT category
T1/T2	65	28 (43.1)		29 (44.6)
T3/T4	98	47 (48.0)	NS	44 (44.9)	NS
pN category
N-negative	71	29 (40.8)		20 (28.2)	14.56
N-positive	92	46 (50.0)	NS	53 (57.6)	< 0.005
WHO classification
Adenocarcinoma	160
Papillary	16	3 (18.8)a		2 (7.1)a
Tubular	109	48 (44.0)		46 (42.2)
Mucinous	24	13 (54.2)	8.47	15 (62.5)	7.05
Signet ring	11	8 (72.7)	< 0.005	7 (63.3)	< 0.01
Undiff. carcinoma	3	3 (100)		3 (100)
Lauren classification
Intestinal type	108	36 (33.3)b	18.18	34 (31.5)b	17.79
Diffuse type	40	29 (72.5)	< 0.005	28 (70.0)	< 0.005
Mixed type	15	10 (66.7)		11 (73.3)

^aPapillary vs Tubular, Mucinous and Signet ring;

^bIntestinal type vs Diffuse type. NS: No Significance